Mandeep Singh

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi request reprint Primary angioplasty should be performed in hospitals without on-site surgery
    Mandeep Singh
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 SW First Street, Rochester, MN 55905, USA
    Catheter Cardiovasc Interv 65:1-7. 2005
  2. doi request reprint Thirty-year trends in outcomes of percutaneous coronary interventions in diabetic patients
    Mandeep Singh
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 88:22-30. 2013
  3. pmc Outcomes of a system-wide protocol for elective and nonelective coronary angioplasty at sites without on-site surgery: the Mayo Clinic experience
    Mandeep Singh
    Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Mayo Clin Proc 84:501-8. 2009
  4. ncbi request reprint A critical appraisal of current models of risk stratification for percutaneous coronary interventions
    Mandeep Singh
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Am Heart J 149:753-60. 2005
  5. ncbi request reprint Prediction of complications following nonemergency percutaneous coronary interventions
    Mandeep Singh
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Am J Cardiol 96:907-12. 2005
  6. pmc Frailty and its potential relevance to cardiovascular care
    Mandeep Singh
    Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Mayo Clin Proc 83:1146-53. 2008
  7. ncbi request reprint Relation of preprocedural statin therapy to in-hospital procedural complications following percutaneous coronary interventions in patients with hyperlipidemia
    Mandeep Singh
    The Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Am J Cardiol 98:325-30. 2006
  8. pmc Mortality differences between men and women after percutaneous coronary interventions. A 25-year, single-center experience
    Mandeep Singh
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Am Coll Cardiol 51:2313-20. 2008
  9. pmc Comorbid conditions and outcomes after percutaneous coronary intervention
    M Singh
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA
    Heart 94:1424-8. 2008
  10. ncbi request reprint Twenty-five-year trends in in-hospital and long-term outcome after percutaneous coronary intervention: a single-institution experience
    Mandeep Singh
    Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Circulation 115:2835-41. 2007

Detail Information

Publications58

  1. ncbi request reprint Primary angioplasty should be performed in hospitals without on-site surgery
    Mandeep Singh
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 SW First Street, Rochester, MN 55905, USA
    Catheter Cardiovasc Interv 65:1-7. 2005
  2. doi request reprint Thirty-year trends in outcomes of percutaneous coronary interventions in diabetic patients
    Mandeep Singh
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 88:22-30. 2013
    ..To characterize in-hospital and long-term outcomes after percutaneous coronary interventions (PCIs) in patients with diabetes mellitus (DM)...
  3. pmc Outcomes of a system-wide protocol for elective and nonelective coronary angioplasty at sites without on-site surgery: the Mayo Clinic experience
    Mandeep Singh
    Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Mayo Clin Proc 84:501-8. 2009
    ..To compare outcomes of percutaneous coronary interventions (PCIs) at 2 community hospitals without on-site surgery (Franciscan Skemp Healthcare and Immanuel St. Joseph's Hospital) with a center with on-site surgery (Saint Marys Hospital)...
  4. ncbi request reprint A critical appraisal of current models of risk stratification for percutaneous coronary interventions
    Mandeep Singh
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Am Heart J 149:753-60. 2005
  5. ncbi request reprint Prediction of complications following nonemergency percutaneous coronary interventions
    Mandeep Singh
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Am J Cardiol 96:907-12. 2005
    ....
  6. pmc Frailty and its potential relevance to cardiovascular care
    Mandeep Singh
    Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Mayo Clin Proc 83:1146-53. 2008
    ..We also elaborate on reasons to consider frailty in older adults with cardiovascular disease and focus on its early identification, on referral to specialists, and on care after serious cardiac events...
  7. ncbi request reprint Relation of preprocedural statin therapy to in-hospital procedural complications following percutaneous coronary interventions in patients with hyperlipidemia
    Mandeep Singh
    The Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Am J Cardiol 98:325-30. 2006
    ..In conclusion, hyperlipidemia per se is not associated with lower in-hospital complications after PCI. The benefit is largely limited to patients on statin treatment...
  8. pmc Mortality differences between men and women after percutaneous coronary interventions. A 25-year, single-center experience
    Mandeep Singh
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Am Coll Cardiol 51:2313-20. 2008
    ..Our aim was to examine whether gender-based differences in mortality after percutaneous coronary interventions (PCIs) have changed in the past 25 years...
  9. pmc Comorbid conditions and outcomes after percutaneous coronary intervention
    M Singh
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA
    Heart 94:1424-8. 2008
    ..To evaluate whether adding comorbid conditions to a risk model can help predict in-hospital outcome and long-term mortality after percutaneous coronary intervention (PCI)...
  10. ncbi request reprint Twenty-five-year trends in in-hospital and long-term outcome after percutaneous coronary intervention: a single-institution experience
    Mandeep Singh
    Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Circulation 115:2835-41. 2007
    ..Little is known about the impact of technological and pharmacological advances on long-term outcome after percutaneous coronary intervention in general clinical practice...
  11. ncbi request reprint Bedside estimation of risk from percutaneous coronary intervention: the new Mayo Clinic risk scores
    Mandeep Singh
    Division of Cardiovascular Diseases, College of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Mayo Clin Proc 82:701-8. 2007
    ..To derive risk models for percutaneous coronary intervention (PCI) outcomes from clinical and laboratory variables available before the procedure so they can be used for preprocedure risk stratification...
  12. doi request reprint Validation of the Mayo clinic risk score for in-hospital mortality after percutaneous coronary interventions using the national cardiovascular data registry
    Mandeep Singh
    Mayo Clinic, Rochester, MN 55905, USA
    Circ Cardiovasc Interv 1:36-44. 2008
    ..External validation using an independent data set would support broader applicability of the model...
  13. doi request reprint Trends in the association between age and in-hospital mortality after percutaneous coronary intervention: National Cardiovascular Data Registry experience
    Mandeep Singh
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn 55905, USA
    Circ Cardiovasc Interv 2:20-6. 2009
    ..We sought to determine the importance of age by assessing the in-hospital mortality of stratified age groups in the National Cardiovascular Data Registry...
  14. ncbi request reprint Risk stratification following acute myocardial infarction
    Mandeep Singh
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic College of Medicine, 200 1st Street South West, Rochester, MN 55905, USA
    Med Clin North Am 91:603-16; x. 2007
    ..This article highlights the models used for ST-elevation MI (STEMI) and non-ST elevation MI (NSTEMI) and provides an additional description of models used to assess risks after primary angioplasty (ie, angioplasty performed for STEMI)...
  15. doi request reprint Influence of frailty and health status on outcomes in patients with coronary disease undergoing percutaneous revascularization
    Mandeep Singh
    Divisions of Cardiovascular Diseases and Department of Health Sciences Research, Division of Endocrinology, Diabetes, Metabolism, and Nutrition, and the Mayo Clinic and Mid America Heart Institute, Rochester, MN 55905, USA
    Circ Cardiovasc Qual Outcomes 4:496-502. 2011
    ..Their inclusion improves the discriminatory ability of the Mayo Clinic risk score derived from the routine cardiovascular risk factors...
  16. doi request reprint Percutaneous coronary intervention at centers with and without on-site surgery: a meta-analysis
    Mandeep Singh
    Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    JAMA 306:2487-94. 2011
    ..Percutaneous coronary interventions are performed at centers without onsite surgery, despite current guidelines discouraging this...
  17. doi request reprint Development and validation of risk adjustment models for long-term mortality and myocardial infarction following percutaneous coronary interventions
    Mandeep Singh
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Circ Cardiovasc Interv 3:423-30. 2010
    ..Our goal was to derive 1- and 5-year mortality and mortality/myocardial infarction (MI) risk models for PCI outcomes from simple, easily obtainable clinical and laboratory variables...
  18. ncbi request reprint Validation of Mayo Clinic risk adjustment model for in-hospital complications after percutaneous coronary interventions, using the National Heart, Lung, and Blood Institute dynamic registry
    Mandeep Singh
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota55905, USA
    J Am Coll Cardiol 42:1722-8. 2003
    ..We sought to validate the recently proposed Mayo Clinic risk score model for complications after percutaneous coronary interventions (PCI), using an independent data set...
  19. ncbi request reprint Comparison of Mayo Clinic risk score and American College of Cardiology/American Heart Association lesion classification in the prediction of adverse cardiovascular outcome following percutaneous coronary interventions
    Mandeep Singh
    Division of Cardiovascular Diseases and Internal Medicine, Rochester, Minnesota, USA
    J Am Coll Cardiol 44:357-61. 2004
    ..We compared American College of Cardiology/American Heart Association (ACC/AHA) lesion classification with the recently proposed Mayo Clinic risk score to predict complications following percutaneous coronary intervention (PCI)...
  20. doi request reprint Safety and efficacy of drug-eluting stent for ST-segment elevation myocardial infarction in an unselected consecutive cohort
    Pieter J Vlaar
    Division of Cardiovascular Disease and Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
    Catheter Cardiovasc Interv 71:764-9. 2008
    ..The objective of this study is to investigate the clinical outcome of a large cohort of patients with ST-segment elevation myocardial infarction (STEMI) treated with drug-eluting stents (DES) compared to bare metal stents (BMS)...
  21. ncbi request reprint Trends in outcomes after percutaneous coronary intervention for chronic total occlusions: a 25-year experience from the Mayo Clinic
    Abhiram Prasad
    Division of Cardiovascular Diseases, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
    J Am Coll Cardiol 49:1611-8. 2007
    ....
  22. ncbi request reprint Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention
    Charanjit S Rihal
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    Circulation 105:2259-64. 2002
    ..In patients undergoing percutaneous coronary intervention (PCI) in the modern era, the incidence and prognostic implications of acute renal failure (ARF) are unknown...
  23. ncbi request reprint Clinical and economic outcomes after introduction of drug-eluting stents
    Charanjit S Rihal
    Division of Cardiovascular Diseases, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Am J Manag Care 16:580-7. 2010
    ..In clinical trials, drug-eluting stents (DES) improve clinical outcomes but are more expensive than bare-metal stents (BMS)...
  24. doi request reprint Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005
    Brendan J Doyle
    Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    JACC Cardiovasc Interv 1:202-9. 2008
    ....
  25. doi request reprint Comparison of frail patients versus nonfrail patients ≥65 years of age undergoing percutaneous coronary intervention
    S Michael Gharacholou
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA
    Am J Cardiol 109:1569-75. 2012
    ..001 for each health status domain). In conclusion, 1/5 of older patients are frail at the time of PCI and have greater comorbid burden, angiographic disease severity, and poorer health status than nonfrail adults...
  26. ncbi request reprint Elective percutaneous coronary intervention without on-site cardiac surgery: clinical and economic implications
    Kirsten Hall Long
    Department of Health Sciences Research, Division of Health Care Policy and Research, Mayo Clinic, Rochester, Minnesota 55905, USA
    Med Care 44:406-13. 2006
    ....
  27. ncbi request reprint Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention
    Mandeep Singh
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Am Coll Cardiol 40:387-93. 2002
    ....
  28. ncbi request reprint Eptifibatide vs abciximab as adjunctive therapy during primary percutaneous coronary intervention for acute myocardial infarction
    Ganesh Raveendran
    Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Mayo Clin Proc 82:196-202. 2007
    ..To compare outcomes among patients receiving eptifibatide or abciximab during primary percutaneous coronary intervention (PCI) for acute myocardial infarction (MI) with ST elevation or new left bundle branch block...
  29. ncbi request reprint Predictive factors for ischemic target vessel revascularization in the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial
    Mandeep Singh
    Division of Internal Medicine and Cardiovascular Diseases, Mayo Clinic and Foundation, 200 Second Street SW, Rochester, MN 55905, USA
    J Am Coll Cardiol 45:198-203. 2005
    ....
  30. ncbi request reprint Scores for post-myocardial infarction risk stratification in the community
    Mandeep Singh
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Foundation, Rochester, Minn 55905, USA
    Circulation 106:2309-14. 2002
    ....
  31. ncbi request reprint Emergency coronary artery bypass surgery for percutaneous coronary interventions: changes in the incidence, clinical characteristics, and indications from 1979 to 2003
    Eric H Yang
    Division of Cardiovascular Disease and Internal Medicine, Mayo College of Medicine, Rochester, Minnesota 55905, USA
    J Am Coll Cardiol 46:2004-9. 2005
    ....
  32. doi request reprint Percutaneous revascularization for stable coronary artery disease temporal trends and impact of drug-eluting stents
    Anthony A Hilliard
    Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
    JACC Cardiovasc Interv 3:172-9. 2010
    ..We sought to determine the characteristics, outcomes, and temporal trends among patients undergoing percutaneous coronary intervention (PCI) for stable coronary artery disease (CAD) from a single-center registry...
  33. doi request reprint Drug-eluting stents in octogenarians: early and intermediate outcome
    Pieter J Vlaar
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Am Heart J 155:680-6. 2008
    ..Large randomized controlled trials have demonstrated that percutaneous coronary intervention with the routine use of drug-eluting stents is safe and effective. However, octogenarians are usually excluded from these trials...
  34. ncbi request reprint Low-risk percutaneous coronary interventions without on-site cardiac surgery: two years' observational experience and follow-up
    Henry H Ting
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
    Am Heart J 145:278-84. 2003
    ..We studied the safety and efficacy of performing low-risk elective and acute infarct percutaneous coronary interventions at a community hospital without cardiac surgical capability...
  35. ncbi request reprint Geographical differences in the rates of angiographic restenosis and ischemia-driven target vessel revascularization after percutaneous coronary interventions: results from the Prevention of Restenosis With Tranilast and its Outcomes (PRESTO) Trial
    Mandeep Singh
    Division of Internal Medicine and Cardiovascular Diseases, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
    J Am Coll Cardiol 47:34-9. 2006
    ..In the absence of a definitive clinical trial to support this view, how should the prudent, cutting-edge cardiologist proceed?..
  36. ncbi request reprint In-hospital and long-term outcomes of multivessel percutaneous coronary revascularization after acute myocardial infarction
    Lin Y Chen
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA
    Am J Cardiol 95:349-54. 2005
    ....
  37. ncbi request reprint Effect of peripheral arterial disease in patients undergoing percutaneous coronary intervention with intracoronary stents
    Mandeep Singh
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Mayo Clin Proc 79:1113-8. 2004
    ....
  38. ncbi request reprint Percutaneous coronary intervention for ST-segment and non-ST-segment elevation myocardial infarction at hospitals with and without on-site cardiac surgical capability
    Mandeep Singh
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Mayo Clin Proc 79:738-44. 2004
    ....
  39. ncbi request reprint A total of 1,007 percutaneous coronary interventions without onsite cardiac surgery: acute and long-term outcomes
    Henry H Ting
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Am Coll Cardiol 47:1713-21. 2006
    ....
  40. doi request reprint Percutaneous coronary intervention in native vessels with angiographically visible thrombus temporal trends and impact of drug-eluting stents
    Manivannan Srinivasan
    Division of Cardiovascular Diseases and Department of Internal Medicine, Mayo Clinic College of Medicine and Mayo Foundation, Rochester, Rochester, Minnesota, USA
    JACC Cardiovasc Interv 3:937-46. 2010
    ..The aim of our study was to evaluate the temporal trends in outcomes following percutaneous coronary intervention in lesions with angiographically visible thrombus and to assess the impact of drug-eluting stents (DES) on long-term outcomes...
  41. doi request reprint Mayo Clinic Risk Score for percutaneous coronary intervention predicts in-hospital mortality in patients undergoing coronary artery bypass graft surgery
    Mandeep Singh
    Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Circulation 117:356-62. 2008
    ..Our goal was to seek a preprocedure risk model that can predict in-hospital mortality after either percutaneous coronary intervention or coronary artery bypass graft surgery...
  42. ncbi request reprint Rheolytic thrombectomy with Angiojet in thrombus-containing lesions
    Mandeep Singh
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Catheter Cardiovasc Interv 56:1-7. 2002
    ..It is effective in both native coronary arteries and vein graft interventions. However, the long-term outcome of patients with vein graft intervention was worse...
  43. doi request reprint Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients
    Abhiram Prasad
    Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minn, USA
    Circ Cardiovasc Interv 1:10-9. 2008
    ..The aim of this study was to evaluate the relative impact of preprocedural and postprocedural cardiac troponin T (cTnT) levels on survival rate after PCI...
  44. ncbi request reprint Treatment of saphenous vein bypass grafts with ultrasound thrombolysis: a randomized study (ATLAS)
    Mandeep Singh
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    Circulation 107:2331-6. 2003
    ..Acolysis (therapeutic ultrasound) can break up thrombus in vitro in animal models and humans. Whether this is beneficial during percutaneous SVG interventions is unknown...
  45. ncbi request reprint Rationale for on-site cardiac surgery for primary angioplasty: a time for reappraisal
    Mandeep Singh
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Am Coll Cardiol 39:1881-9. 2002
    ....
  46. ncbi request reprint Myocardial perfusion in apical ballooning syndrome correlate of myocardial injury
    Ahmad Elesber
    Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
    Am Heart J 152:469.e9-13. 2006
    ..This study evaluated myocardial perfusion abnormalities at the time of presentation in patients with ABS and examined whether abnormal microvascular blood flow predicts the extent of myocardial injury...
  47. doi request reprint Assessment of individual operator performance using a risk-adjustment model for percutaneous coronary interventions
    Mario Gossl
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN
    Mayo Clin Proc 88:1250-8. 2013
    ..To investigate the applicability of the Mayo Clinic Risk Score (MCRS) in the assessment of performance metrics of individual interventional cardiologists at 3 Mayo Clinic sites...
  48. pmc Cognitive impairment and outcomes in older adult survivors of acute myocardial infarction: findings from the translational research investigating underlying disparities in acute myocardial infarction patients' health status registry
    S Michael Gharacholou
    Mayo Clinic, Rochester, MN, USA
    Am Heart J 162:860-869.e1. 2011
    ..Cognitive impairment without dementia (CIND) and acute myocardial infarction (AMI) are prevalent in older adults; however, the association of CIND with outcomes after AMI is unknown...
  49. ncbi request reprint Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: insights from the Prevention of Restenosis With Tranilast and Its Outcomes (PRESTO) trial
    Mandeep Singh
    Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minn 55905, USA
    Circulation 109:2727-31. 2004
    ..The aim of the present study was to include the clinical and angiographic variables commonly associated with angiographic restenosis and develop a prediction model for restenosis from the PRESTO database...
  50. ncbi request reprint Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality
    Abhiram Prasad
    Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Am Coll Cardiol 48:1765-70. 2006
    ..The aim of this study was to evaluate whether, in patients with normal post-procedure CK-MB, an isolated elevation in cardiac troponin T (cTnT) predicts long-term survival...
  51. ncbi request reprint Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock: insights from the GUSTO-I trial
    Mandeep Singh
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Am Coll Cardiol 50:1752-8. 2007
    ..This study sought to assess long-term outcome and determine its predictors among 30-day survivors of cardiogenic shock...
  52. pmc Measuring frailty in heart failure: a community perspective
    Sheila M McNallan
    Department of Health Sciences Research, Mayo Clinic, Rochester, MN
    Am Heart J 166:768-74. 2013
    ..Each method has strengths and limitations, but their utility has never been evaluated in the same community HF cohort...
  53. ncbi request reprint Telemedicine links between developing and developed nations
    Mandeep Singh
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Indian Heart J 55:188-92. 2003
  54. ncbi request reprint Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score
    Amir Halkin
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA
    J Am Coll Cardiol 45:1397-405. 2005
    ..We sought to develop a simple risk score for predicting mortality after primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI)...
  55. doi request reprint Survival benefit with concomitant clopidogrel and glycoprotein IIb/IIIa inhibitor therapy at ad hoc percutaneous coronary intervention
    Richard J Gumina
    Ohio State University, Columbus, USA
    Mayo Clin Proc 83:995-1001. 2008
    ..To study clinical outcomes in patients given glycoprotein (GP) IIb/IIIa inhibitors with concomitant clopidogrel at the time of ad hoc percutaneous coronary interventions (PCI)...
  56. ncbi request reprint The predicament of offering elective percutaneous coronary intervention at sites without on-site cardiac surgery
    Mandeep Singh
    Am Heart J 152:810-1. 2006
  57. ncbi request reprint Guidelines, lighthouses, and a toe in the water
    David R Holmes
    Circulation 112:2754-5. 2005
  58. ncbi request reprint Progesterone and the risk of preterm birth among women with a short cervix
    Eduardo B Fonseca
    Harris Birthright Research Centre for Fetal Medicine, King s College Hospital, London, United Kingdom
    N Engl J Med 357:462-9. 2007
    ..Asymptomatic women found at midgestation to have a short cervix are at greatly increased risk for spontaneous early preterm delivery, and it is unknown whether progesterone reduces this risk in such women...